Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
- PMID: 12691741
- DOI: 10.1016/s1044-7431(02)00032-5
Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
Abstract
Several molecules inhibit axonal growth cones and may account for the failure of central nervous system regeneration, including myelin proteins and various chondroitan sulfate proteoglycans expressed at the site of injury. Axonal growth inhibition by myelin and chondroitan sulfate proteoglycans may in part be controlled by Rho-GTPase, which mediates growth cone collapse. Here, we tested in vitro whether pharmacological inhibition of a major downstream effector of Rho, Rho-kinase, promotes axonal outgrowth from dorsal root ganglia grown on aggrecan. Aggrecan substrates stimulated Rho activity and were inhibitory to axonal growth. Y-27632 treatment promoted the growth of axons by 5- to 10-fold and induced "steamlined" growth cones with longer filopodia and smaller lamellipodia. Interestingly, more actin bundles reminiscent of stress fibers in the central domain of the growth cone were observed when grown on aggrecan compared to laminin. In addition, Y-27632 significantly promoted axonal growth on both myelin and adult rat spinal cord cryosections. Our data suggest that suppression of Rho-kinase activity may enhance axonal regeneration in the central nervous system.
Similar articles
-
Rho kinase inhibition enhances axonal regeneration in the injured CNS.J Neurosci. 2003 Feb 15;23(4):1416-23. doi: 10.1523/JNEUROSCI.23-04-01416.2003. J Neurosci. 2003. PMID: 12598630 Free PMC article.
-
Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord.J Neurosci. 2009 Dec 2;29(48):15266-76. doi: 10.1523/JNEUROSCI.4650-09.2009. J Neurosci. 2009. PMID: 19955379 Free PMC article.
-
The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar.Mol Cell Neurosci. 2003 Mar;22(3):319-30. doi: 10.1016/s1044-7431(02)00035-0. Mol Cell Neurosci. 2003. PMID: 12691734
-
Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.Curr Pharm Des. 2007;13(24):2493-9. doi: 10.2174/138161207781368657. Curr Pharm Des. 2007. PMID: 17692017 Review.
-
Rho-ROCK inhibitors for the treatment of CNS injury.Recent Pat CNS Drug Discov. 2007 Nov;2(3):173-9. doi: 10.2174/157488907782411738. Recent Pat CNS Drug Discov. 2007. PMID: 18221230 Review.
Cited by
-
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor.Chin J Traumatol. 2016;19(1):16-24. doi: 10.1016/j.cjtee.2015.09.008. Chin J Traumatol. 2016. PMID: 27033267 Free PMC article.
-
[Voluntary micturition after intradural nerve anastomosis].Urologe A. 2005 Jul;44(7):756-61. doi: 10.1007/s00120-005-0849-x. Urologe A. 2005. PMID: 15959611 Review. German.
-
The oligodendrocyte growth cone and its actin cytoskeleton: A fundamental element for progenitor cell migration and CNS myelination.Glia. 2020 Jul;68(7):1329-1346. doi: 10.1002/glia.23735. Epub 2019 Nov 7. Glia. 2020. PMID: 31696982 Free PMC article. Review.
-
α-Tubulin Acetyltransferase Is a Novel Target Mediating Neurite Growth Inhibitory Effects of Chondroitin Sulfate Proteoglycans and Myelin-Associated Glycoprotein.eNeuro. 2018 Feb 28;5(1):ENEURO.0240-17.2018. doi: 10.1523/ENEURO.0240-17.2018. eCollection 2018 Jan-Feb. eNeuro. 2018. PMID: 29497702 Free PMC article.
-
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.Brain. 2012 Nov;135(Pt 11):3355-70. doi: 10.1093/brain/aws254. Epub 2012 Oct 19. Brain. 2012. PMID: 23087045 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources